Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
73 participants
INTERVENTIONAL
2015-04-30
2016-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Factors Associated With the Use of a High Volume Cancer Center by Black Women With Ovarian Cancer: A Qualitative Study
NCT02928549
Role of Spirituality in Coping and Surviving With Ovarian Cancer, Primary Peritoneal or Fallopian Tube Cancer
NCT00499512
The Effectiveness of an Online Support Group in Enhancing Recovery Identity and Health-Related Quality of Life
NCT06145295
Biobehavioral and Sociodemographic Characteristics of Long Term Survivors of Ovarian Cancer
NCT02043158
Health Benefits of Writing Therapy Among Asian American Cancer Survivors
NCT06367959
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
SUPPORTIVE_CARE
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Expressive Writing
Writing about ovarian cancer: Participants will be asked to write about their deepest thoughts and emotions about their experience with ovarian cancer
Expressive Writing
Participants will be asked to write about their deepest thoughts and emotions about their experience with ovarian cancer
Fact Writing (Control)
Writing about ovarian cancer: Participants will be asked to write about the facts of their experience with ovarian cancer
Fact Writing (Control)
Participants will be asked to write about the facts of their experience with ovarian cancer
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Expressive Writing
Participants will be asked to write about their deepest thoughts and emotions about their experience with ovarian cancer
Fact Writing (Control)
Participants will be asked to write about the facts of their experience with ovarian cancer
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* At least 18 years old
* English-speaking/Can comfortably read and write in English
* Able to provide informed consent
* Internet access
* Valid email address
* Any region/country
Exclusion Criteria
* Lack of English proficiency
* Inability to provide informed consent
* Male
18 Years
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Maryland, College Park
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Mary Ann Hoffman, Ph.D.
Role: STUDY_CHAIR
University of Maryland, College Park
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University of Maryland, College Park
College Park, Maryland, United States
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Merz EL, Fox RS, Malcarne VL. Expressive writing interventions in cancer patients: a systematic review. Health Psychol Rev. 2014;8(3):339-61. doi: 10.1080/17437199.2014.882007. Epub 2014 Feb 18.
Frattaroli J. Experimental disclosure and its moderators: a meta-analysis. Psychol Bull. 2006 Nov;132(6):823-65. doi: 10.1037/0033-2909.132.6.823.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
728101-3
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.